Millennium Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-325,237
| Closed | -$413K | – | 6844 |
|
|
2023
Q3 | $413K | Buy |
325,237
+199,402
| +158% | +$174K | ﹤0.01% | 4762 |
|
|
2023
Q2 | $41K | Sell |
125,835
-330,514
| -72% | -$118K | ﹤0.01% | 5511 |
|
|
2023
Q1 | $196K | Sell |
456,349
-103,789
| -19% | -$54.7K | ﹤0.01% | 5180 |
|
|
2022
Q4 | $297K | Sell |
560,138
-37,462
| -6% | -$23.8K | ﹤0.01% | 5118 |
|
|
2022
Q3 | $437K | Buy |
597,600
+294,049
| +97% | +$334K | ﹤0.01% | 5078 |
|
|
2022
Q2 | $346K | Buy |
+303,551
| New | +$387K | ﹤0.01% | 5249 |
|
|
2021
Q4 | – | Sell |
-387,602
| Closed | -$1.64M | – | 7576 |
|
|
2021
Q3 | $1.64M | Sell |
387,602
-852
| -0.2% | -$3.8K | ﹤0.01% | 4141 |
|
|
2021
Q2 | $2.06M | Buy |
388,454
+366,074
| +1,636% | +$1.76M | ﹤0.01% | 3924 |
|
|
2021
Q1 | $104K | Buy |
+22,380
| New | +$101K | ﹤0.01% | 5683 |
|
|
2020
Q4 | – | Sell |
-197,080
| Closed | -$652 | – | 5707 |
|
|
2020
Q3 | $652 | Sell |
197,080
-17,723
| -8% | -$65.1K | ﹤0.01% | 3435 |
|
|
2020
Q2 | $724K | Buy |
+214,803
| New | +$1.02M | ﹤0.01% | 3187 |
|
|
2019
Q4 | – | Sell |
-23,336
| Closed | -$176K | – | 4743 |
|
|
2019
Q3 | $176K | Buy |
23,336
+5,479
| +31% | +$61.8K | ﹤0.01% | 3824 |
|
|
2019
Q2 | $242K | Sell |
17,857
-2,853
| -14% | -$32.9K | ﹤0.01% | 3666 |
|
|
2019
Q1 | $112K | Sell |
20,710
-9,894
| -32% | -$48.1K | ﹤0.01% | 3836 |
|
|
2018
Q4 | $91K | Sell |
30,604
-123,299
| -80% | -$675K | ﹤0.01% | 3550 |
|
|
2018
Q3 | $1.26M | Sell |
153,903
-70,608
| -31% | -$542K | ﹤0.01% | 2742 |
|
|
2018
Q2 | $2.19M | Buy |
224,511
+120,570
| +116% | +$1.24M | ﹤0.01% | 2332 |
|
|
2018
Q1 | $903K | Buy |
+103,941
| New | +$1.12M | ﹤0.01% | 2746 |
|
|
2017
Q3 | – | Sell |
-16,772
| Closed | -$285K | – | 3969 |
|
|
2017
Q2 | $285K | Sell |
16,772
-14,526
| -46% | -$289K | ﹤0.01% | 3063 |
|
|
2017
Q1 | $629K | Buy |
+31,298
| New | +$622K | ﹤0.01% | 2677 |
|
Millennium Management's ZYNE Position: Q4 2023 in Review
Millennium Management sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2023, closing a stake of 325,237 shares — an estimated $413K sold.
Millennium Management first reported a position in ZYNE in Q1 2017 and held it in 20 quarters. The position peaked at $2.19M in Q2 2018. 0 funds tracked by Wall St. Rank hold ZYNE as of Q4 2023.
- Millennium Management reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2023 after selling out during the quarter.
- Millennium Management sold 325,237 Zynerba Pharmaceuticals, Inc shares in Q4 2023, an estimated $413K.
- Millennium Management first reported a position in Zynerba Pharmaceuticals, Inc in Q1 2017 and held it in 20 quarters.
- Millennium Management's Zynerba Pharmaceuticals, Inc position peaked at $2.19M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2023.
Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.